157 related articles for article (PubMed ID: 17632742)
1. Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
Osteoporos Int; 2007 Dec; 18(12):1675-81. PubMed ID: 17632742
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Sugimoto T
Osteoporos Int; 2011 Apr; 22(4):1191-8. PubMed ID: 20532480
[TBL] [Abstract][Full Text] [Related]
4. Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes.
Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
Calcif Tissue Int; 2009 Sep; 85(3):228-34. PubMed ID: 19641839
[TBL] [Abstract][Full Text] [Related]
5. Assessment using serum insulin-like growth factor-I and bone mineral density is useful for detecting prevalent vertebral fractures in patients with type 2 diabetes mellitus.
Kanazawa I; Notsu M; Miyake H; Tanaka K; Sugimoto T
Osteoporos Int; 2018 Nov; 29(11):2527-2535. PubMed ID: 30030585
[TBL] [Abstract][Full Text] [Related]
6. Decreased Serum Insulin-like Growth Factor-I is a Risk Factor for Non-vertebral Fractures in Diabetic Postmenopausal Women.
Miyake H; Kanazawa I; Sugimoto T
Intern Med; 2017; 56(3):269-273. PubMed ID: 28154269
[TBL] [Abstract][Full Text] [Related]
7. Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes.
Yamamoto M; Yamaguchi T; Yamauchi M; Yano S; Sugimoto T
J Clin Endocrinol Metab; 2008 Mar; 93(3):1013-9. PubMed ID: 18160470
[TBL] [Abstract][Full Text] [Related]
8. Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus.
Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
Eur J Endocrinol; 2009 Feb; 160(2):265-73. PubMed ID: 18996964
[TBL] [Abstract][Full Text] [Related]
9. Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus.
Kanazawa I; Yano S; Yamaguchi T; Notsu Y; Nabika T; Sugimoto T
Clin Endocrinol (Oxf); 2010 Oct; 73(4):463-8. PubMed ID: 20550537
[TBL] [Abstract][Full Text] [Related]
10. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
[TBL] [Abstract][Full Text] [Related]
11. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women.
Nakaoka D; Sugimoto T; Kaji H; Kanzawa M; Yano S; Yamauchi M; Sugishita T; Chihara K
Osteoporos Int; 2001; 12(7):548-54. PubMed ID: 11527051
[TBL] [Abstract][Full Text] [Related]
12. Combination of obesity with hyperglycemia is a risk factor for the presence of vertebral fractures in type 2 diabetic men.
Kanazawa I; Yamaguchi T; Yamamoto M; Yamauchi M; Yano S; Sugimoto T
Calcif Tissue Int; 2008 Nov; 83(5):324-31. PubMed ID: 18946627
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
[TBL] [Abstract][Full Text] [Related]
14. Higher Serum Uric Acid is a Risk Factor of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes Mellitus.
Tanaka KI; Kanazawa I; Notsu M; Sugimoto T
Exp Clin Endocrinol Diabetes; 2020 Jan; 128(1):66-71. PubMed ID: 30562825
[TBL] [Abstract][Full Text] [Related]
15. Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes.
Yamaguchi T; Kanazawa I; Yamamoto M; Kurioka S; Yamauchi M; Yano S; Sugimoto T
Bone; 2009 Aug; 45(2):174-9. PubMed ID: 19446053
[TBL] [Abstract][Full Text] [Related]
16. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
Yamamoto M; Yamaguchi T; Nawata K; Yamauchi M; Sugimoto T
J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
[TBL] [Abstract][Full Text] [Related]
17. The contribution of IGF-I to skeletal integrity in postmenopausal women.
Muñoz-Torres M; Mezquita-Raya P; Lopez-Rodriguez F; Torres-Vela E; de Dios Luna J; Escobar-Jimenez F
Clin Endocrinol (Oxf); 2001 Dec; 55(6):759-66. PubMed ID: 11895218
[TBL] [Abstract][Full Text] [Related]
18. Increased low-density lipoprotein cholesterol level is associated with non-vertebral fractures in postmenopausal women.
Yamauchi M; Yamaguchi T; Nawata K; Tanaka K; Takaoka S; Sugimoto T
Endocrine; 2015 Feb; 48(1):279-86. PubMed ID: 24853884
[TBL] [Abstract][Full Text] [Related]
19. Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women: a population-based study.
Nabipour I; Larijani B; Beigi S; Jafari SM; Amiri M; Assadi M; Pazoki R; Amiri Z; Sanjdideh Z
Menopause; 2008; 15(5):934-9. PubMed ID: 18451743
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women.
Bonadonna S; Mazziotti G; Nuzzo M; Bianchi A; Fusco A; De Marinis L; Giustina A
J Bone Miner Res; 2005 Oct; 20(10):1837-44. PubMed ID: 16160741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
